{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:56:02Z","timestamp":1795190162847,"version":"4.10.3"},"reference-count":49,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>In their 2014 article \u201cNew Immunohistochemistry for B-cell Lymphoma and Hodgkin Lymphoma,\u201d Zhang and Aguilera reviewed new immunohistochemical markers for B-cell lymphoma and Hodgkin lymphoma and described how to use these markers for correct lymphoma diagnoses, using the 2008 World Health Organization classifications. Recently, the World Health Organization\u2019s WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues published 2022 updates, and, in quick sequence, a second group published an alternative International Consensus Classification of myeloid neoplasms, acute leukemias, and mature lymphoid neoplasms. Regardless of the system a hematopathologist chooses to follow, updates in the immunohistochemical diagnosis of disease are described in both publications as well as in the primary literature. In addition to updated classifications, the increasing use of small biopsy samples for the evaluation of lymphadenopathy continues to challenge hematopathology diagnosis and increase the utilization of immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To review new immunohistochemical markers or new uses of previously known immunohistochemical markers in the evaluation of hematolymphoid neoplasia for the practicing hematopathologist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>Data were obtained from a literature review and personal practice experience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>The practicing hematopathologist requires knowledge of the ever-expanding repertoire of immunohistochemistry for the diagnosis and treatment of hematolymphoid neoplasia. New markers presented in this article help to complete our understanding of disease, diagnosis, and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2022-0465-ra","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T15:09:40Z","timestamp":1685891380000},"page":"292-298","source":"Crossref","is-referenced-by-count":7,"title":["Updates in Immunohistochemistry for Hematopoietic and Lymphoid Neoplasms"],"prefix":"10.5858","volume":"148","author":[{"given":"Haluk","family":"Kavus","sequence":"first","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology, Geisinger Medical Center, Danville, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology, Geisinger Medical Center, Danville, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dhesi","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology, Geisinger Medical Center, Danville, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"(12)","key":"2024022617191140700_i1543-2165-148-3-292-b01","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.5858\/arpa.2014-0058-RA","article-title":"New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma","volume":"138","author":"Zhang","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"2024022617191140700_i1543-2165-148-3-292-b02","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"4th ed."},{"issue":"(7)","key":"2024022617191140700_i1543-2165-148-3-292-b03","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"(7)","key":"2024022617191140700_i1543-2165-148-3-292-b04","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"2024022617191140700_i1543-2165-148-3-292-b05","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"Revised 4th ed."},{"issue":"(11)","key":"2024022617191140700_i1543-2165-148-3-292-b06","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"(11)","key":"2024022617191140700_i1543-2165-148-3-292-b07","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"(3)","key":"2024022617191140700_i1543-2165-148-3-292-b08","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4274\/tjh.galenos.2021.2021.0349","article-title":"Relevance of additional immunohistochemical markers in the differential diagnosis of small B-cell lymphomas: a case-control study","volume":"39","author":"K\u0131vrak","year":"2022","journal-title":"Turk J Haematol"},{"issue":"(3)","key":"2024022617191140700_i1543-2165-148-3-292-b09","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ajcp\/aqy144","article-title":"IRTA1 and MNDA expression in marginal zone lymphoma: utility in differential diagnosis and implications for classification","volume":"151","author":"Wang","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"2024022617191140700_i1543-2165-148-3-292-b10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2022.01.001","article-title":"Immunohistochemistry for LEF1 and SOX11 adds diagnostic specificity in small B-cell lymphomas","volume":"121","author":"Rangan","year":"2022","journal-title":"Hum Pathol"},{"key":"2024022617191140700_i1543-2165-148-3-292-b11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.humpath.2022.04.004","article-title":"Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma","volume":"125","author":"Ravindran","year":"2022","journal-title":"Hum Pathol"},{"issue":"(5)","key":"2024022617191140700_i1543-2165-148-3-292-b12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PAI.0000000000000738","article-title":"Myeloid cell nuclear differentiation antigen (MNDA) positivity in primary follicles: potential pitfall in the differential diagnosis with marginal zone lymphoma","volume":"28","author":"Manohar","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"(3)","key":"2024022617191140700_i1543-2165-148-3-292-b13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/ijlh.13420","article-title":"Downregulation of lymphoid enhancer-binding factor 1 (LEF-1) expression (by immunohistochemistry and\/ flow cytometry) in chronic lymphocytic leukemia with atypical immunophenotypic and cytologic features","volume":"43","author":"Soliman","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"(5)","key":"2024022617191140700_i1543-2165-148-3-292-b14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ajcp\/aqz207","article-title":"Immunohistochemical expression of lymphoid enhancer binding factor 1 in CD5-positive marginal zone, lymphoplasmacytic, and follicular lymphomas","volume":"153","author":"Patel","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"(8)","key":"2024022617191140700_i1543-2165-148-3-292-b15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":"CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"issue":"(7)","key":"2024022617191140700_i1543-2165-148-3-292-b16","doi-asserted-by":"crossref","first-page":"108403","DOI":"10.1016\/j.celrep.2020.108403","article-title":"Cyclin D3 governs clonal expansion of dark zone germinal center B cells","volume":"33","author":"Ramezani-Rad","year":"2020","journal-title":"Cell Rep"},{"issue":"(8)","key":"2024022617191140700_i1543-2165-148-3-292-b17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2016-11-751024","article-title":"Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations","volume":"129","author":"Curiel-Olmo","year":"2017","journal-title":"Blood"},{"key":"2024022617191140700_i1543-2165-148-3-292-b18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.humpath.2018.10.038","article-title":"Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma","volume":"85","author":"Pizzi","year":"2019","journal-title":"Hum Pathol"},{"issue":"(10)","key":"2024022617191140700_i1543-2165-148-3-292-b19","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood.V94.10.3567.422k06_3567_3575","article-title":"The MAL gene is expressed in primary mediastinal large B-cell lymphoma","volume":"94","author":"Copie-Bergman","year":"1999","journal-title":"Blood"},{"issue":"(6)","key":"2024022617191140700_i1543-2165-148-3-292-b20","first-page":"396","article-title":"Immunohistochemistry with anti-MAL antibody and RNAscope with MAL probes are complementary techniques for diagnosis of primary mediastinal large B-cell lymphoma","volume":"74","author":"Jacquier","year":"2020","journal-title":"J Clin Pathol"},{"issue":"(7)","key":"2024022617191140700_i1543-2165-148-3-292-b21","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.4049\/jimmunol.1400531","article-title":"Putting J chain back on the map: how might its expression define plasma cell development?","volume":"193","author":"Castro","year":"2014","journal-title":"J Immunol"},{"key":"2024022617191140700_i1543-2165-148-3-292-b22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2017.08.015","article-title":"J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"68","author":"Moore","year":"2017","journal-title":"Hum Pathol"},{"issue":"(3)","key":"2024022617191140700_i1543-2165-148-3-292-b23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/PAI.0000000000000581","article-title":"GATA3 immunohistochemical staining in Hodgkin lymphoma: diagnostic utility in differentiating classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and other mimicking entities","volume":"27","author":"Kezlarian","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"(1)","key":"2024022617191140700_i1543-2165-148-3-292-b24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13000-019-0918-x","article-title":"Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma","volume":"14","author":"Kim","year":"2019","journal-title":"Diagn Pathol"},{"issue":"(2)","key":"2024022617191140700_i1543-2165-148-3-292-b25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajcp\/aqac044","article-title":"IRF8 as a novel marker to differentiate between CD30-positive large cell lymphomas","volume":"158","author":"McQuaid","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"2024022617191140700_i1543-2165-148-3-292-b26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.anndiagpath.2019.04.009","article-title":"The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma","volume":"40","author":"Aladily","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"(1)","key":"2024022617191140700_i1543-2165-148-3-292-b27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/PAS.0000000000001180","article-title":"Utility of combined EZH2, p-ERK1\/2, p-STAT, and MYC expression in the differential diagnosis of EZH2-positive hodgkin lymphomas and related large B-cell lymphomas","volume":"43","author":"Tian","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"(1)","key":"2024022617191140700_i1543-2165-148-3-292-b28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cas.15191","article-title":"Clinicopathological significance of CD28 overexpression in adult T-cell leukemia\/lymphoma","volume":"113","author":"Sakamoto","year":"2022","journal-title":"Cancer Sci"},{"issue":"(1)","key":"2024022617191140700_i1543-2165-148-3-292-b29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: from bench to bedside","volume":"27","author":"Yoshie","year":"2015","journal-title":"Int Immunol"},{"issue":"(7)","key":"2024022617191140700_i1543-2165-148-3-292-b30","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2018-02-835991","article-title":"CCR4 mutations associated with superior outcome of adult T-cell leukemia\/lymphoma under mogamulizumab treatment","volume":"132","author":"Sakamoto","year":"2018","journal-title":"Blood"},{"issue":"(1)","key":"2024022617191140700_i1543-2165-148-3-292-b31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cjp2.180","article-title":"Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia\/lymphoma","volume":"7","author":"Fujii","year":"2021","journal-title":"J Pathol Clin Res"},{"issue":"(4)","key":"2024022617191140700_i1543-2165-148-3-292-b32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/jclinpath-2020-206476","article-title":"Abnormal expression of p-ATM\/CHK2 in nasal extranodal NK\/T cell lymphoma, nasal type, is correlated with poor prognosis","volume":"74","author":"Ye","year":"2021","journal-title":"J Clin Pathol"},{"issue":"(6)","key":"2024022617191140700_i1543-2165-148-3-292-b33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjh.17681","article-title":"B-cell lymphoma\/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia\/lymphoma (ETP-ALL\/LBL) from other subtypes of T-cell ALL\/LBL","volume":"194","author":"Fang","year":"2021","journal-title":"Br J Haematol"},{"issue":"(2)","key":"2024022617191140700_i1543-2165-148-3-292-b34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrc3418","article-title":"LIM-domain-only proteins in cancer","volume":"13","author":"Matthews","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"(20)","key":"2024022617191140700_i1543-2165-148-3-292-b35","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"(12)","key":"2024022617191140700_i1543-2165-148-3-292-b36","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.3390\/cancers13123102","article-title":"T-cell lymphoblastic lymphoma arising in the setting of myeloid\/lymphoid neoplasms with eosinophilia: LMO2 immunohistochemistry as a potentially useful diagnostic marker","volume":"13","author":"Zanelli","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"(10)","key":"2024022617191140700_i1543-2165-148-3-292-b37","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/PAS.0000000000001765","article-title":"IRF8 is a reliable monoblast marker for acute monocytic leukemias","volume":"45","author":"Katz","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"(5)","key":"2024022617191140700_i1543-2165-148-3-292-b38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/PAS.0000000000001874","article-title":"IRF8 is a reliable monoblast marker for acute monocytic leukemias, but does not discriminate between monoblasts and plasmacytoid dendritic cells","volume":"46","author":"Tzankov","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"(2)","key":"2024022617191140700_i1543-2165-148-3-292-b39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/ajcp\/aqac034","article-title":"GLUT1 Immunohistochemistry is a highly sensitive and relatively specific marker for erythroid lineage in benign and malignant hematopoietic tissues","volume":"158","author":"Kaumeyer","year":"2022","journal-title":"Am J Clin Pathol"},{"issue":"(6)","key":"2024022617191140700_i1543-2165-148-3-292-b40","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/his.12221","article-title":"CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis","volume":"63","author":"Morgado","year":"2013","journal-title":"Histopathology"},{"issue":"(1)","key":"2024022617191140700_i1543-2165-148-3-292-b41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaci.2015.05.008","article-title":"Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis","volume":"137","author":"\u00c1lvarez-Twose","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2024022617191140700_i1543-2165-148-3-292-b42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.leukres.2016.02.010","article-title":"Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin","volume":"44","author":"Borate","year":"2016","journal-title":"Leuk Res"},{"issue":"(6)","key":"2024022617191140700_i1543-2165-148-3-292-b43","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.humpath.2011.08.005","article-title":"c-kit gene mutation and CD117 expression in human anorectal melanomas","volume":"43","author":"Ni","year":"2012","journal-title":"Hum Pathol"},{"issue":"(12)","key":"2024022617191140700_i1543-2165-148-3-292-b44","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"(5)","key":"2024022617191140700_i1543-2165-148-3-292-b45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jclinpath-2015-203175","article-title":"Immunohistochemical detection of cytoplasmic nucleophosmin in formalin-fixed paraffin-embedded marrow trephine biopsies in acute myeloid leukaemia","volume":"69","author":"Lit","year":"2016","journal-title":"J Clin Pathol"},{"issue":"(6)","key":"2024022617191140700_i1543-2165-148-3-292-b46","first-page":"763","article-title":"Nucleophosmin mutation analysis in acute myeloid leukaemia: immunohistochemistry as a surrogate for molecular techniques","volume":"143","author":"Chopra","year":"2016","journal-title":"Indian J Med Res"},{"issue":"(4)","key":"2024022617191140700_i1543-2165-148-3-292-b47","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/his.14726","article-title":"Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia","volume":"81","author":"Fitzpatrick","year":"2022","journal-title":"Histopathology"},{"issue":"(2)","key":"2024022617191140700_i1543-2165-148-3-292-b48","first-page":"e35","article-title":"Characterization of myeloid malignancies with TP53 mutations and comparison to P53 expression by immunohistochemical staining methods","volume":"42","author":"Karner","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"(5)","key":"2024022617191140700_i1543-2165-148-3-292-b49","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PAS.0000000000000970","article-title":"Characterization of IDH1 p.R132H mutant clones using mutation-specific antibody in myeloid neoplasms","volume":"42","author":"Kurt","year":"2018","journal-title":"Am J Surg Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/3\/292\/3334335\/i1543-2165-148-3-292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/3\/292\/3334335\/i1543-2165-148-3-292.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:23Z","timestamp":1764790823000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/148\/3\/article-p292.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6,1]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2022-0465-ra","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,1]]}}}